Woyach, J. A., Ruppert, A. S., Heerema, N. A., Peterson, B. L., Gribben, J. G., Morrison, V. A., . . . Byrd, J. C. (2011). Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712. American Society of Clinical Oncology.
Chicago-stil citatWoyach, Jennifer A., Amy S. Ruppert, Nyla A. Heerema, Bercedis L. Peterson, John G. Gribben, Vicki A. Morrison, Kanti R. Rai, Richard A. Larson, och John C. Byrd. Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712. American Society of Clinical Oncology, 2011.
MLA-referensWoyach, Jennifer A., et al. Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712. American Society of Clinical Oncology, 2011.